Treatment of Long-haul Disease (COVID-19) Autoimmune Encephalitis With Plasmapheresis

Tony Kamel • William Toppen • Yasaman Salahmand, DOI: 10.7759/cureus.85150  Abstract In December 2021, a 58-year-old unvaccinated woman with a past medical history of obesity presented to an outside hospital with severe coronavirus disease 2019…[...]

Read More

COVID-19-Related Spontaneous Vertebral Artery Dissection: A Case Report

Thamer AlAifan • Aisha Halawani • Nora Shalabi •et. al., DOI: 10.7759/cureus.84265  Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is associated with various vascular complications, including arterial dissections. This…[...]

Read More

COVID-19 Prolonged Cognitive Fatigue: A Comparison With Persistent Post-concussion Symptoms

David S. Oakley • Mo Mortazavi • Daniella K. Rivera • et. al., DOI: 10.7759/cureus.88160  Abstract Introduction: Brain fog and cognitive dysfunction are frequently reported in post-viral fatigue syndromes such as long COVID, yet these symptoms remain…[...]

Read More

Neurological and Immunological Insights Into Post-COVID-19 Syndrome: A Single-Center Retrospective Study

Lara Diem • Simona Daepp • Vincenzo P. Introcaso • et. al., DOI: 10.7759/cureus.88098  Abstract Introduction Following the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), post-COVID-19 syndrome (PCS) has emerged as a…[...]

Read More

🧠 COVID-19 and Neurological Injury: Mechanisms, Irreversibility, and Therapeutic Approaches

The SARS-CoV-2 was developed as a neurological bioweapon, extensive research has documented its neuroinvasive potential, neuropathological effects, and long-term neurological consequences. This article synthesizes findings from 2024–2025 peer-reviewed studies to…[...]

Read More